IPO registrations (S-1, F-1) · Registrants
CATALYST PHARMACEUTICALS, INC.
- SEC CIK
- 1369568 · filings on EDGAR ↗
- Name on the registration
- CATALYST PHARMACEUTICAL PARTNERS, INC.
- Former names
- Catalyst Pharmaceutical Partners, Inc. (2011–2015); CATALYST PHARMACEUTICAL PARTNERS, INC. (2011–2015)
- Registration
- Form S-1, first filed 2006-07-25, last 2012-05-04; 2 initial registrations, 7 amendments
- Outcome
- Final prospectus filed 2006-11-08; declared effective 2006-11-07
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 355 ALHAMBRA CIRCLE, SUITE 801, Coral Gables, FL 33134
- EDGAR entity type
- operating
- Insiders and CEO pay
- CATALYST PHARMACEUTICALS, INC. on the corporate pages
Offering terms
- Final price
- $1.14 per share (424B4 filed 2006-11-08, an initial public offering)
- Shares sold
- 3,350,000
- Gross proceeds
- $3,819,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol CPRX
- Lead underwriters
- Stifel (1,172,500 shares)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: Catalyst Pharmaceuticals, Inc. Fuzzy (name and state)
- Business registration: Catalyst Pharmaceuticals, Inc. Fuzzy (name and state)
- Business registration: CATALYST PHARMACEUTICALS, INC. Fuzzy (name and state)
- Business registration: CATALYST PHARMACEUTICALS, INC. Fuzzy (name and state)
- Business registration: CATALYST PHARMACEUTICALS, INC. Fuzzy (name and state)
- Business registration: CATALYST PHARMACEUTICALS, INC. Fuzzy (name and state)
- Federal award recipient: CATALYST PHARMACEUTICALS, INC Fuzzy (name and state)
- Lobbying client: CATALYST PHARMACEUTICALS Fuzzy (name and state)
- Lobbying client: CATALYST PHARMACEUTICALS Fuzzy (name and state)
- SEC filer: Catalyst Pharmaceutical Partners, Inc. EXACT (CIK (EXACT))
- Person page: Milton J Wallace Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Patrick J Mcenany Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Other))
Filings 20
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2006-07-25 | S-1 | S-1 (registration) | Catalyst Pharmaceutical Partners, Inc. | 0000950144-06-006906 ↗ |
| 2006-09-01 | S-1/A | S-1/A (amendment) | Catalyst Pharmaceutical Partners, Inc. | 0000950144-06-008469 ↗ |
| 2006-09-26 | S-1/A | S-1/A (amendment) | Catalyst Pharmaceutical Partners, Inc. | 0000950144-06-009063 ↗ |
| 2006-10-04 | S-1/A | S-1/A (amendment) | Catalyst Pharmaceutical Partners, Inc. | 0000950144-06-009258 ↗ |
| 2006-10-18 | S-1/A | S-1/A (amendment) | Catalyst Pharmaceutical Partners, Inc. | 0000950144-06-009581 ↗ |
| 2006-11-07 | S-1/A | S-1/A (amendment) | Catalyst Pharmaceutical Partners, Inc. | 0000950144-06-010324 ↗ |
| 2006-11-07 | EFFECT | EFFECT (declared effective) | Catalyst Pharmaceutical Partners, Inc. | 9999999995-06-002203 ↗ |
| 2006-11-08 | 424B4 | 424B4 (final prospectus) | Catalyst Pharmaceutical Partners, Inc. | 0000950144-06-010451 ↗ |
| 2008-06-26 | EFFECT | EFFECT (declared effective) | Catalyst Pharmaceutical Partners, Inc. | 9999999995-08-002035 ↗ |
| 2010-12-15 | EFFECT | EFFECT (declared effective) | Catalyst Pharmaceutical Partners, Inc. | 9999999995-10-003597 ↗ |
| 2012-04-06 | S-1 | S-1 (registration) | CATALYST PHARMACEUTICAL PARTNERS, INC. | 0001193125-12-153699 ↗ |
| 2012-04-25 | S-1/A | S-1/A (amendment) | CATALYST PHARMACEUTICAL PARTNERS, INC. | 0001193125-12-179641 ↗ |
| 2012-05-04 | S-1/A | S-1/A (amendment) | CATALYST PHARMACEUTICAL PARTNERS, INC. | 0001193125-12-210518 ↗ |
| 2012-05-07 | EFFECT | EFFECT (declared effective) | CATALYST PHARMACEUTICAL PARTNERS, INC. | 9999999995-12-001442 ↗ |
| 2012-05-16 | EFFECT | EFFECT (declared effective) | CATALYST PHARMACEUTICAL PARTNERS, INC. | 9999999995-12-001577 ↗ |
| 2012-05-23 | EFFECT | EFFECT (declared effective) | CATALYST PHARMACEUTICAL PARTNERS, INC. | 9999999995-12-001630 ↗ |
| 2012-05-24 | 424B4 | 424B4 (final prospectus) | CATALYST PHARMACEUTICAL PARTNERS, INC. | 0001193125-12-246194 ↗ |
| 2012-08-31 | EFFECT | EFFECT (declared effective) | CATALYST PHARMACEUTICAL PARTNERS, INC. | 9999999995-12-002633 ↗ |
| 2013-12-03 | EFFECT | EFFECT (declared effective) | CATALYST PHARMACEUTICAL PARTNERS, INC. | 9999999995-13-003419 ↗ |
| 2014-03-19 | EFFECT | EFFECT (declared effective) | CATALYST PHARMACEUTICAL PARTNERS, INC. | 9999999995-14-000696 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2006-11-07 | S-1/A | registration statement | $6.00 | 3,350,000 | $20,100,000 | Nasdaq CPRX | 1 | primary document; price sentence, shares headline, proceeds computed, cover names 1 | document ↗ | |
| 2006-11-08 | 424B4 | final prospectus | $1.14 | 3,350,000 | $3,819,000 | Nasdaq CPRX | 1 | primary document; price line, shares headline, proceeds computed, underwriting table 1, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| COELHO PHILIP H | Director | 55 | 2006–2023 | ||
| HUCKEL HUBERT E MD | Director; Director,TenPercentOwner | 15 | 2006–2014 | ||
| MCENANY PATRICK J | Director,Officer; Director,Officer,TenPercentOwner; Director,Other | Chairman and CEO; Chairman, President and CEO; President and CEO; President and Chief Executive | 92 | 2006–2026 | person page Fuzzy |
| O'Keeffe Charles B | Director | 72 | 2006–2025 | ||
| Tierney David S | Director | 50 | 2006–2026 | ||
| WALLACE MILTON J | Director | 18 | 2006–2012 | person page Fuzzy | |
| Weinstein Jack | Officer | V.P., Treasurer & CFO | 14 | 2006–2010 | |
| Winship M Douglas | Officer | V.P. of Regulatory Operations; VP, Regulatory Operations | 13 | 2006–2015 | |
| GRANDE ALICIA | Officer | Chief Accounting Officer; Chief Financial Officer; Controller & CAO; VP, Treasurer and CFO | 42 | 2007–2023 | |
| Miller Steve | Officer | Chief Operating Officer; Chief Oper./Scientific Officer; Chief Op. & Scientific Officer; VP Development & Management | 50 | 2007–2026 | |
| Rieger Richard | Officer | VP Commercial Operations | 1 | 2011 | |
| BIOMARIN PHARMACEUTICAL INC | TenPercentOwner | 2 | 2012 | ||
| MUTH DAVID D | Officer | EVP, Chief Commercial Officer; Exec. V.P., Corp. Development | 5 | 2014–2015 | |
| Daly Richard J | Director; Director,Officer | President and CEO | 33 | 2015–2026 | |
| DENKHAUS DONALD A | Director | 43 | 2015–2026 | ||
| INGENITO GARY | Officer | Chief Medical Officer; Chief Medical & Reg. Officer; Chief Med. & Reg. Officer | 34 | 2015–2025 | |
| Merrigan Paul J | Officer | Chief Commercial Officer | 3 | 2015–2016 | |
| BRENNAN DANIEL | Officer | Chief Commercial Officer | 3 | 2018–2019 | |
| Elsbernd Brian | Officer | Chief Compliance/Legal Officer; Chief Legal Officer | 29 | 2019–2026 | |
| Del Carmen Jeffrey | Officer | Chief Commercial Officer | 27 | 2020–2026 | |
| Harper Molly | Director | 20 | 2021–2026 | ||
| Sundaram Preethi | Officer | Chief Product Devel. Officer; Chief Strategy Officer | 19 | 2021–2026 | |
| Thompson Tamar | Director | 7 | 2023–2026 | ||
| Kalb Michael Wayne | Officer | Chief Financial Officer; Executive Vice President & CFO | 6 | 2024–2026 | |
| Russo Gregg | Officer | Chief HR Officer | 5 | 2025–2026 | |
| Andrews William T. | Officer | Chief Medical Officer | 4 | 2025–2026 | |
| Curran Daniel J. | Director | 3 | 2025–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | Catalyst Pharmaceuticals, Inc. | FL | State business registries | name and state |
| Business registration | Catalyst Pharmaceuticals, Inc. | FL | State business registries | name and state |
| Business registration | CATALYST PHARMACEUTICALS, INC. | FL | State business registries | name and state |
| Business registration | CATALYST PHARMACEUTICALS, INC. | FL | State business registries | name and state |
| Business registration | CATALYST PHARMACEUTICALS, INC. | FL | State business registries | name and state |
| Business registration | CATALYST PHARMACEUTICALS, INC. | FL | State business registries | name and state |
| Plan sponsor | CATALYST PHARMACEUTICALS, INC. | FL | Form 5500 (employee benefit plans) | name and state |
| Federal award recipient | CATALYST PHARMACEUTICALS, INC | FL | Federal spending (USAspending) | name and state |
| Lobbying client | CATALYST PHARMACEUTICALS | FL | Federal lobbying (LDA) | name and state |
| Lobbying client | CATALYST PHARMACEUTICALS | FL | Federal lobbying (LDA) | name and state |
| Paying company | CATALYST PHARMACEUTICALS, INC. | FL | Open Payments (drug and device company payments) | name and state |
| Patent assignee | Catalyst Pharmaceuticals, Inc. | FL | Patents (USPTO) | name and state |
| SEC filer | CATALYST PHARMACEUTICALS, INC. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Catalyst Pharmaceuticals, Inc. | FL | Trademarks (USPTO) | name and state |
| Person page | Milton J Wallace | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Patrick J Mcenany | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Other) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, FL first:
- SANO CORP FL
- CTT PHARMACEUTICAL HOLDINGS, INC. FL
- Inhibitor Therapeutics, Inc. FL
- GENEREX BIOTECHNOLOGY CORP FL
- BIOMOLECULAR LIFE HOLDINGS, INC. FL
- Alaunos Therapeutics, Inc. FL
- ORAGENICS INC FL
- Polomar Health Services, Inc. FL
- ACCENTIA BIOPHARMACEUTICALS INC FL
- NOMAD POWER SOLUTIONS, INC. FL
In other datasets, the same topic (Health) in FL:
- Nonprofit: 414 WELLWOMEN INC (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health